Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review

Lung cancer is the leading cause of cancer-related death in worldwide. The most important treatment for patients with stage I and II non-small cell lung cancer (NSCLC) is surgery. Resected stage II and III NSCLC patients should be offered adjuvant chemotherapy and in patients with resected stage IB...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Transl Lung Cancer Res
Main Authors: Calvo, Virginia, Aliaga, Carlos, Carracedo, Carlos, Provencio, Mariano
פורמט: Artigo
שפה:Inglês
יצא לאור: AME Publishing Company 2021
נושאים:
Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867763/
https://ncbi.nlm.nih.gov/pubmed/33569338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-515
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים